ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc.

NEW YORK, July 24, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and its board of directors concerning the proposed acquisition of the company by Palvella Therapeutics, Inc. Pieris Pharmaceuticals stockholders are expected to own approximately 18% of the combined company. The transaction is expected to close in the fourth quarter of 2024.

If you are a stockholder of Pieris Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/pirs/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

SOURCE Rowley Law PLLC